Agfa's Open Letter to De Tijd, Mediafin and De Persgroep

Agfa HealthCareDear Sir, I noted that De Tijd, and Bert Broens in particular, is continuing without abatement its 'damage Agfa-Gevaert' campaign. In recent months, we have noticed that this journalist continuously reports on Agfa-Gevaert in a one-sided negative manner and that he doesn't hesitate to publish inaccurate information.

The most striking examples were the articles published just before the General Meeting of Shareholders held in April. In these articles, he claimed that a number of important Agfa-Gevaert shareholders would vote against certain agenda items. When we checked this with our shareholders, the information turned out to be completely false. Templeton, our main shareholder, even felt forced to issue a press release to deny the content of the articles. In this case it is clear that even the most elementary rules of objective journalism were not observed.

Another example is a series of articles with completely false information about a possible operation involving Agfa Graphics. Insiders in the business know that this campaign was inspired by the management of Punch. I leave it to you to decide if this is ethically acceptable.

More recently, the campaign is aimed at Agfa HealthCare. This business group's important successes, such as the huge contract signed with the Paris hospitals, were minimized. In today's article some details were used to create a completely negative image.

It is obvious that we are not able to win every single contract. If that would be the case, we would hold a monopoly. Furthermore, it is only normal that occasionally a colleague leaves the company. It seems to me that this shouldn't be a reason for this type of negative coverage either.

Regarding this article, not a single contact was made with our company in order to at least check the accuracy of the information or to obtain additional information.

Again, I leave it to you to judge the quality of this kind of journalism.

I personally have put all means of communication at Bert Broens' disposal, my private mobile phone number included. I believe I can't do more than that.

Agfa-Gevaert is one of the few Belgian companies with very important global market shares in almost all of its activities. This goes for both our graphic and our healthcare business. Our competitors are therefore only too anxious to translate and spread this kind of articles amongst our customers.

Why a newspaper, which is presenting itself as the newspaper for the entrepreneurs in Flanders, is leading such a damaging campaign, goes beyond my comprehension.

It will therefore come to you as no surprise that I will demand - as a right to reply - the publication of a text from my hand, of comparable length in De Tijd.

In my opinion, this is the strict minimum that can be done to somewhat limit the significant economic damage created by this campaign.

Jo Cornu
CEO Agfa-Gevaert

Related news articles:

About Agfa
The Agfa-Gevaert Group is one of the world's leading imaging and information technology companies. Agfa develops, manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), the healthcare sector (Agfa HealthCare) and specific industrial applications (Agfa Materials). Agfa's headquarters are in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries throughout the world. The Agfa-Gevaert Group achieved a turnover of 3,283 million Euro in 2007.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading provider of IT-enabled clinical workflow and diagnostic image management solutions, and state-of-the-art systems for capturing and processing images in hospitals and healthcare facilities. Agfa HealthCare has over a century of healthcare experience related to diagnostic imaging and has been a pioneer on the healthcare IT market since the early 1990's. The HealthCare division has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2007 were 1,392 million Euro, accounting for 43% of total group sales. For more information on Agfa HealthCare, please visit www.agfa.com/healthcare.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...